This Analyst Loves Depomed And Its Nucynta Prescription

By: via Benzinga
In a report issued Friday, Roth Capital analyst Scott R. Henry provided an update of prescriptions for Nucynta, a franchise recently ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.